San Francisco, March 10, 2016 -- According to a new report by Grand View Research, the global electrophysiology devices market is projected to reach $6.18 billion by 2020 with a CAGR of 5%. Growing occurrence of cardiac arrhythmias and elderly population base are the key market drivers. The global market has witnessed a huge rise in the usage rates of the electrophysiology devices in the recent years, with physicians increasingly getting experience in diagnostics & ablation techniques. The advent of technological advancements, like nanostim leadless pacemaker development, is also projected to boost the device usage rates.
Diagnostic electrophysiology catheters are projected to grow at the rate of 15% in the forecast period (2014–2020). Fast-paced growth witnessed in this segment, mainly because catheter ablation has become the first line of treatment for various rhythm disorders due to its ability to render success rates of about 95 percent.
Browse to access In-depth research report on Global Electrophysiology Devices Market with detailed charts and figures: http://www.grandviewresearch.com/industry-analysis/electrophysiology-devices-market
Electrophysiology monitoring devices & electrophysiology treatment devices are the two application sectors analyzed in this report. Electrophysiology monitoring devices accounted for about 60% of the total share in 2013. X-ray systems came up as the topmost electrophysiology monitoring sector in 2013. Increased portable & digital systems usage, improving interventional & diagnostic abilities of healthcare practitioners, is one of the major market growth drivers. The electrophysiology treatment devices sector includes pacemakers, implantable cardioverter defibrillators (ICD), & catheters. In 2013, catheters came up as the biggest treatment devices sub-segment. Widespread usage of treatment devices in electrophysiology studies & increasing interventional procedures’ volume are some of the key factors accounting for the segment’s biggest share.
Request for free sample of this research report: http://www.grandviewresearch.com/industry-analysis/electrophysiology-devices-market/request
In 2013, North America was the biggest regional market accounting for over 30% of the total share. Increased awareness levels amongst patients and sophisticated healthcare infrastructure supporting large interventional procedures volumes are some of the major aspects accounting for the region’s large share. On the other hand, Asia-Pacific is projected to witness huge growth opportunities, mainly because of the great prevalence of patients with highly unmet medical requirements. Moreover, increase expenditure levels & rapidly developing healthcare infrastructure in the rising markets of China & India are providing great opportunities for the companies to capitalize on in the forecast period.
Some of the major electrophysiology devices manufacturers are Medtronic Inc., Abbott Laboratories, St. Jude Medical, Biotronik SE & Co. KG, and Boston Scientific Corporation.
Browse related reports by Grand View Research:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-electrophysiology-devices-market
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
email: [email protected]
Web: www.grandviewresearch.com


Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
OpenAI Explores Massive Funding Round at $750 Billion Valuation
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 



